116 related articles for article (PubMed ID: 1906119)
21. Effects of YM-14673, a new thyrotropin-releasing hormone analogue, on impaired learning of passive avoidance in mice.
Yamamoto M; Ozawa Y; Takeuchi H
Arch Int Pharmacodyn Ther; 1993; 321():5-13. PubMed ID: 8100705
[TBL] [Abstract][Full Text] [Related]
22. The effect of tacrine (THA) on cycloheximide- and basal forebrain lesion-induced memory deficit in rats.
Nabeshima T; Maruyama E; Katoh A; Kameyama T
Jpn J Pharmacol; 1991 Nov; 57(3):311-9. PubMed ID: 1813659
[TBL] [Abstract][Full Text] [Related]
23. Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide (DM-9384) on learning and memory in rats.
Sakurai T; Ojima H; Yamasaki T; Kojima H; Akashi A
Jpn J Pharmacol; 1989 May; 50(1):47-53. PubMed ID: 2724699
[TBL] [Abstract][Full Text] [Related]
24. The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats.
Foley AG; Murphy KJ; Hirst WD; Gallagher HC; Hagan JJ; Upton N; Walsh FS; Regan CM
Neuropsychopharmacology; 2004 Jan; 29(1):93-100. PubMed ID: 14571256
[TBL] [Abstract][Full Text] [Related]
25. NS-3, a TRH-analog, reverses memory disruption by stimulating cholinergic and noradrenergic systems.
Ogasawara T; Itoh Y; Tamura M; Ukai Y; Yoshikuni Y; Kimura K
Pharmacol Biochem Behav; 1996 Feb; 53(2):391-9. PubMed ID: 8808149
[TBL] [Abstract][Full Text] [Related]
26. Effects of TA-0910, an orally active TRH analog, on the spinal reflex in spinal rats.
Kinoshita K; Nagao T; Ono H
Neuropharmacology; 1994 Oct; 33(10):1183-8. PubMed ID: 7862253
[TBL] [Abstract][Full Text] [Related]
27. NS-3(CG3703), a TRH analog, ameliorates scopolamine-induced memory disruption in rats.
Ogasawara T; Nakagawa Y; Ukai Y; Tamura M; Kimura K
Pharmacol Biochem Behav; 1995 Aug; 51(4):929-34. PubMed ID: 7675879
[TBL] [Abstract][Full Text] [Related]
28. SK-PC-B70M from Pulsatilla koreana improves scopolamine-induced impairments of memory consolidation and spatial working memory.
Han CK; Park YH; Jin DQ; Hwang YK; Oh KB; Han JS
Brain Res; 2007 Dec; 1184():254-9. PubMed ID: 17976545
[TBL] [Abstract][Full Text] [Related]
29. An evaluation of the mechanism of scopolamine-induced impairment in two passive avoidance protocols.
Elrod K; Buccafusco JJ
Pharmacol Biochem Behav; 1988 Jan; 29(1):15-21. PubMed ID: 3353420
[TBL] [Abstract][Full Text] [Related]
30. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
Kinoshita K; Fujitsuka T; Yamamura M; Matsuoka Y
Eur J Pharmacol; 1995 Feb; 274(1-3):65-72. PubMed ID: 7768282
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (II): Involvement of the DA system in the locomotor stimulating action of TA-0910.
Yamamura M; Kinoshita K; Nakagawa H; Ishida R
Jpn J Pharmacol; 1991 Jan; 55(1):57-68. PubMed ID: 1904114
[TBL] [Abstract][Full Text] [Related]
32. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice.
Hiramatsu M; Inoue K
Br J Pharmacol; 1999 Jun; 127(3):655-60. PubMed ID: 10401555
[TBL] [Abstract][Full Text] [Related]
33. TRH protection against memory retrieval deficits is independent of endocrine effects.
Stwertka SA; Vincent GP; Gamzu ER; MacNeil DA; Verderese AG
Pharmacol Biochem Behav; 1992 Jan; 41(1):145-52. PubMed ID: 1539064
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments.
Mansouri MT; Farbood Y; Naghizadeh B; Shabani S; Mirshekar MA; Sarkaki A
Pharm Biol; 2016 Oct; 54(10):1947-53. PubMed ID: 26828763
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacological studies on sufoxazine (Y-8894). (I) Effects on experimental amnesia in mice].
Anami K; Yamamoto Y; Setoguchi M
Nihon Yakurigaku Zasshi; 1985 Feb; 85(2):71-7. PubMed ID: 2859238
[TBL] [Abstract][Full Text] [Related]
36. Minaprine cancels scopolamine effects on the rat's acquisition of passive avoidance responses in two multitrial paradigms.
Ambrogi Lorenzini C; Baldi E; Bucherelli C; Tassoni G
Pharmacol Biochem Behav; 1992 Apr; 41(4):715-8. PubMed ID: 1594638
[TBL] [Abstract][Full Text] [Related]
37. Negative and positive effects of intracerebroventricular scopolamine on memory in mice undergoing passive avoidance and escape tests.
Nakajima M; Inui A; Miura M; Hirosue Y; Okita M; Himori N; Baba S; Kasuga M
Brain Res Bull; 1994; 34(4):375-80. PubMed ID: 8082028
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (III): Inhibition of pentobarbital anesthesia.
Yamamura M; Kinoshita K; Nakagawa H; Ishida R
Jpn J Pharmacol; 1991 Jan; 55(1):69-80. PubMed ID: 1904115
[TBL] [Abstract][Full Text] [Related]
39. Involvement of dorsal hippocampal alpha-adrenergic receptors in the effect of scopolamine on memory retrieval in inhibitory avoidance task.
Azami NS; Piri M; Oryan S; Jahanshahi M; Babapour V; Zarrindast MR
Neurobiol Learn Mem; 2010 May; 93(4):455-62. PubMed ID: 20064624
[TBL] [Abstract][Full Text] [Related]
40. Comparative studies on the effects of the nootropic drugs adafenoxate, meclofenoxate and piracetam, and of citicholine on scopolamine-impaired memory, exploratory behavior and physical capabilities (experiments on rats and mice).
Petkov VD; Mosharrof AH; Petkov VV
Acta Physiol Pharmacol Bulg; 1988; 14(1):3-13. PubMed ID: 3136617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
